Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom

Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C andHaemophilus influenzaeType b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age

(2010) Elizabeth Miller et al.   Clinical and Vaccine Immunology

Immunogenicity of Alternative Regimens of the Conjugated 7-Valent Pneumococcal Vaccine

(2010) Noga Givon-Lavi et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months

(2010) Javier Díez-Domingo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Glycoconjugate vaccines and immune interference: A review

(2010) Ron Dagan et al.   VACCINE

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

(2009) R. Borrow et al.   Clinical and Vaccine Immunology

Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United Kingdom

(2008) J. Southern et al.   Clinical and Vaccine Immunology